Horizon Biologicals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-04-2024
- Paid Up Capital ₹ 0.20 M
as on 21-04-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -15.38%
(FY 2019)
- Profit 9.76%
(FY 2019)
- Ebitda
- Net Worth -0.32%
(FY 2019)
- Total Assets -0.18%
(FY 2019)
About Horizon Biologicals (India)
- CIN/LLPIN
U24231MH2002PTC136786
- Company No.
136786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2002
- Date of AGM
21 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Horizon Biologicals (India)?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Patidar  | Director | 09-Aug-2002 | Current |
| Balraj Misra | Director | 09-Aug-2002 | Current |
| Purti Misra | Director | 09-Aug-2002 | Current |
| Renu Dave | Director | 09-Aug-2002 | Current |
| Narendra Dave | Director | 09-Aug-2002 | Current |
| Padma Patidar | Director | 09-Aug-2002 | Current |
Financial Performance of Horizon Biologicals (India).
Horizon Biologicals (India) Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.38% decrease. The company also saw a slight improvement in profitability, with a 9.76% increase in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Horizon Biologicals (India)?
In 2019, Horizon Biologicals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Allied Biotechnology India Private LimitedActive 16 years 6 monthsPadma Patidar and Manohar Patidar are mutual person
Pirincs Pharmaceuticals Private LimitedActive 9 years 3 daysBalraj Misra and Purti Misra are mutual person
- Elephanta Construction Co. Private LimitedActive 20 years 9 months
Balraj Misra and Purti Misra are mutual person
- Grihasti Enterprises Private LimitedActive 9 years 11 months
Balraj Misra and Purti Misra are mutual person
- Pirinc Enterprises Private LimitedActive 9 years 11 months
Balraj Misra and Purti Misra are mutual person
- Mohammdi Healthcare Systems Private LimitedActive 19 years 7 months
Balraj Misra and Purti Misra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Horizon Biologicals (India)?
Unlock and access historical data on people associated with Horizon Biologicals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horizon Biologicals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horizon Biologicals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
